Hulu just become home to the largest selection of FX Networks content available through tablets, smartphones, gaming platforms and other Internet-connected devices.

The streaming service announced on Thursday that it closed a deal with Twentieth Century Fox Television Distribution for the exclusive subscription video on demand rights to new and upcoming FX and FXX primetime comedy, drama and miniseries in a new, multi-year agreement for FX Networks’ series produced or co-produced by FX Productions (FXP).

See video: Fox News’ Megyn Kelly Talks ‘The Interview,’ Doesn’t Know if She Did ‘the Right Thing’ By Reporting on Sony Emails Released by Hackers (Video)

Upcoming FX Networks’ series that will be exclusive to Hulu in the SVOD window include the comedy series “Man Seeking Woman” starring Jay Baruchel, “The Comedians” starring Billy Crystal and Josh Gad, “Sex&Drugs&Rock&Roll” starring Denis Leary and John Corbett, period drama “Taboo” starring Tom Hardy from executive producer Ridley Scott, and “Baskets” starring Zach Galifianakis.

Additionally, Fox’s upcoming M. Night Shyamalan event series, “Wayward Pines,” will stream exclusively on Hulu. Matt Dillon, Terrence Howard and Melissa Leo star in the series that premieres on May 14.

See video: Bill O’Reilly Declares ‘We Won’ the ‘War on Christmas’

Current season FX Networks series will remain available via the FXNOW app to authenticated subscribers through their MVPD provider.

As part of the deal, both Hulu and FX Networks will work together to market their exclusive pact. Hulu, for example, will provide FX on- and off-site branding to reinforce the association of the shows with the FX brand.

“FX Productions shares the same commitment to creating and distributing distinctive, high quality programming that we do here at Hulu,” senior vice president, head of content, Craig Erwich said in a statement. “We are thrilled to begin this partnership, which will add a wide variety of popular series, and fresh, yet-to-air series to our ever expanding roster of great content.”

More to come…